Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by University Hospital, Bonn.
Recruitment status was  Recruiting
Information provided by:
University Hospital, Bonn Identifier:
First received: July 27, 2005
Last updated: February 1, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2010
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)